Henry Schein HSIC Redeemable NCI
Redeemable NCI at other companies
Other financials
Where this comes from
Reported directly by Henry Schein in its filing.
Tagged under the XBRL concept us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests.
The official record: Henry Schein’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Henry Schein's redeemable nci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Henry Schein's redeemable NCI?
- Henry Schein (HSIC) reported redeemable NCI of $903M in Q1 2026.
- How has Henry Schein's redeemable NCI changed year-over-year?
- Henry Schein's redeemable NCI increased by 18.0% year-over-year, from $765M to $903M.
- What is the long-term trend for Henry Schein's redeemable NCI?
- Over 5 years (2020 to 2025), Henry Schein's redeemable NCI has grown at a 22.2% compound annual growth rate (CAGR), from $328M to $895M.
- What does redeemable NCI mean?
- Equity held by others in a subsidiary that the company may be required to buy back.
- How do you interpret redeemable NCI?
- An increase suggests higher potential future cash obligations, while a decrease indicates the settlement or expiration of redemption rights.
- How does redeemable NCI compare across companies?
- Common in companies with joint ventures or acquisitions involving earn-out provisions or put options.